Tower Research Capital (TRC)’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Sell |
22,124
-7,610
| -26% | -$85.8K | 0.01% | 1586 |
|
|
2025
Q1 | $300K | Sell |
29,734
-33,724
| -53% | -$340K | 0.01% | 1141 |
|
|
2024
Q4 | $751K | Buy |
63,458
+56,534
| +816% | +$669K | 0.01% | 803 |
|
|
2024
Q3 | $79.9K | Sell |
6,924
-3,454
| -33% | -$39.9K | ﹤0.01% | 2412 |
|
|
2024
Q2 | $110K | Sell |
10,378
-252,670
| -96% | -$2.67M | ﹤0.01% | 2520 |
|
|
2024
Q1 | $2.77M | Buy |
263,048
+253,377
| +2,620% | +$2.67M | 0.07% | 209 |
|
|
2023
Q4 | $109K | Sell |
9,671
-2,660
| -22% | -$29.9K | ﹤0.01% | 2589 |
|
|
2023
Q3 | $144K | Buy |
12,331
+962
| +8% | +$11.2K | ﹤0.01% | 1695 |
|
|
2023
Q2 | $115K | Sell |
11,369
-3,306
| -23% | -$33.3K | ﹤0.01% | 1923 |
|
|
2023
Q1 | $108K | Buy |
14,675
+12,353
| +532% | +$90.9K | ﹤0.01% | 1805 |
|
|
2022
Q4 | $18K | Sell |
2,322
-3,054
| -57% | -$23.7K | ﹤0.01% | 3231 |
|
|
2022
Q3 | $17K | Sell |
5,376
-18,123
| -77% | -$57.3K | ﹤0.01% | 4080 |
|
|
2022
Q2 | $95K | Buy |
23,499
+17,737
| +308% | +$71.7K | ﹤0.01% | 2338 |
|
|
2022
Q1 | $28K | Buy |
5,762
+5,114
| +789% | +$24.9K | ﹤0.01% | 3229 |
|
|
2021
Q4 | $7K | Buy |
+648
| New | +$7K | ﹤0.01% | 4935 |
|